Finding the Sweet Spot
How proper site activation and site enrollment can help you get the most from clinical trials.
Science and Safety
All the focus on drug safety raises concerns about FDA delays in approving new drugs for market.
Explaining Innovation
Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle.
The Book on Daniel
Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that?
Animal Testing: Terrorism and the Militant Fringe
The militant fringe of animal rights activists targets pharma.
Innovation By Design
Executives should embrace design to discover new markets and find new ways to server customers.
Making Big Waves
How a small competitor benefited from the use of interactive marketing.
End the "Hard Stop"
Leaders manage their time and focus their resources by limiting unwanted interruptions.
Think Different
Game-changers can create competitive advantages for pharmaceutical companies and products.
